Project overview

There is considerable concern about increasing antidepressant use in England. GPs are giving out more than 50 million prescriptions a year, to more than 1 in 10 adults.

Some people need long-term antidepressants to stop them getting depressed, but a third to a half could probably stop them without relapsing. However, stopping is not easy, due to withdrawal symptoms including anxiety and low mood which are usually temporary but feel similar to the reason why patients were first put on antidepressants. So understandably some people restart their antidepressant quickly. Others are reluctant to try stopping because they feel well on medication and are afraid their symptoms may come back.

People taking antidepressants have told us their GPs often do not review them and just give repeat prescriptions. Studies show that when GPs review patients on long-term antidepressants and advise them where appropriate to withdraw, only 1 in 14 is able to stop. Patients can be fearful and withdrawal can be tricky so GPs and Nurse Practitioners (NPs) who prescribe anti-depressants need to guide patients who want to withdraw, and patients need around the clock support.

• We aim to identify feasible, safe, reliable and cost-effective (value for money) ways of helping patients withdraw from long-term antidepressants, where this is appropriate.

• We will first review all published relevant research, to identify successful ways to help patients withdraw from treatment.

• We will identify the difficulties in withdrawing, and things that patients and practitioners think might help withdrawal, through interviews with patients taking antidepressants long-term, and through focus groups with GPs, NPs and primary care mental health workers (PCMHWs).

• We will try out support through the Internet for patients, and their GPs, to help them.

• An interactive programme will be developed to help support patient withdrawal from antidepressants, available around the clock.

• It will be developed through a process of 'co-design' and 'co-production' which means taking the views of patients and practitioners into account throughout its development and initial trial run.

• We will also explore whether 'buddying' support from people who have come off antidepressants might help.

• We will check the usefulness of the programme in helping patients stop treatment through a randomised controlled trial in three centres, and estimate financial benefits for the NHS.

• If the programme works we will spread it throughout the NHS, by publishing practical guidance for professionals, and advice for patients to follow, publicised through patient support groups.

We have developed the ideas for this project with the help of people having long-term treatment for depression. They will continue to work with us to help make sense of the information we gather, and advise on the support we develop for antidepressant withdrawal, from the patient’s point of view.

Contact: [email protected]

Staff

Lead researchers

Professor Tony Kendrick BSc MD FRCGP FRCPsych FHEA

Professor of Primary Care
Connect with Tony

Other researchers

Dr Judith Joseph BSc, MSc, PhD

Senior Research Enterprise Fellow

Research interests

  • Developing and implementing digital health interventions
  • Behaviour change
  • Patient and Public Involvement
Connect with Judith

Professor Geraldine Leydon

Prof of Medicine, Sociology & Healthcare

Research interests

  • Healthcare communication
  • Qualitative methods in health reesarch 
  • Optimising the patient experience
Connect with Geraldine

Professor Paul Little

Professor in Primary Care Research
Connect with Paul

Dr Adam Geraghty BSc MSc PhD CPsychol FHEA

Assoc Prof Psychology & Behavioural Med

Research interests

  • Self-management of pain and other chronic symptoms/conditions
  • Mental health
  • Digital interventions for primary care and public health
Connect with Adam

Professor Gareth Griffiths

Director SCTU & Prof of Clinical Trials

Research interests

  • Gareth Griffiths is Professor of Clinical Trials and directs our Southampton Clinical Trials Unit.  He works with clinicians, research groups and other scientists in the development of important clinical trials and other well-designed studies that aim to improve the treatment of a range of cancers and other diseases, and early diagnosis of cancer.
  • His works spans the different phases of clinical trials, from small dose finding and safety studies involving a handful of patients to larger trials of hundreds of patients looking at whether the treatments are better than the current standard treatments.  His early diagnosis studies include thousands of patients looking at new ways to detect cancer early.  Ultimately, these studies could help change the way that patients are treated for the better, by creating the evidence so as the new treatments becomes the standard of care for future patients treated in the NHS.
  • Phase I-III clinical trials
Connect with Gareth

Collaborating research institutes, centres and groups

Research outputs

Tony Kendrick, Beth Stuart, Hannah Bowers, Mahboobeh Haji Sadeghi, Helen Page, Christopher Dowrick, Michael Moore, Mark Gabbay, Geraldine M. Leydon, Guiqing Lily Yao, Paul Little, Gareth Griffiths, Glyn Lewis, Carl May, Joanna Moncrieff, Chris F. Johnson, Una Macleod, Simon Gilbody, Rachel Dewar-Haggart, Samantha Williams, Wendy O'Brien, Riya Tiwari, Catherine Woods, Tasneem Patel, Naila Khan, Nadja van Ginneken, Amy Din, Claire Reidy, Rebecca Lucier, Bryan Palmer, Taeko Becque, Ellen van Leeuwen, Shihua Zhu & Adam W.A. Geraghty, 2024, JAMA Network Open, 7(6)
Type: article